We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT04581382
Brief Title: Radiation Therapy, Plasma Exchange, and Immunotherapy (Pembrolizumab or Nivolumab) for the Treatment of Melanoma

First Submitted : September 18, 2020
First Submitted that Met QC Criteria : October 5, 2020
First Posted : October 9, 2020

Last Update Submitted that Met QC Criteria : January 5, 2023
Last Update Posted : January 6, 2023